HLB SCIENCE Inc. (XKON:343090)
South Korea · Delayed Price · Currency is KRW 1,554.00
+4.00 (0.26%)
Last updated: Aug 11, 2025
HLB SCIENCE Company Description
HLB SCIENCE Inc. develops biological drugs with MoA to infectious diseases.
Its pipeline includes DD-S052P, a candidate that exterminates germs and eliminates endotoxins; DD-A279, a new treatment to cure Alzheimer's Diseases by controlling LPS and Gram-negative bacteria; and DD-A514, a diagnosis kit for Alzheimer's diseases.
The company was formerly known as Dandi Bio Science Co.,Ltd. and changed its name to HLB SCIENCE Inc. in March 2023.
The company was founded in 2016 and is based in Seoul, South Korea.
HLB SCIENCE Inc.
| Country | South Korea |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
| CEO | Yoon Jongsun |
Contact Details
Address: 66, Achasan-ro Seoul, 04782 South Korea | |
| Phone | 82 2 6925 0379 |
| Website | hlbscience.com |
Stock Details
| Ticker Symbol | 343090 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yoon Jongsun | Chief Executive Officer |